• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA approves Sanofi’s long-lasting hemophilia drug

cafead

Administrator
Staff member
  • cafead   Feb 23, 2023 at 04:42: PM
via The Food and Drug Administration on Thursday approved a new hemophilia therapy that has the potential to be a more convenient option for some patients and, according to analysts, a lucrative product for its developers.

article source
 

<